Package leaflet: Information for the patient. Naloxone Hydrochloride 20 micrograms / ml Solution for Injection Naloxone hydrochloride



Similar documents
Package leaflet : information for the user. Dilute Adrenaline/Epinephrine Injection 1:10,000 adrenaline (epinephrine) (as acid tartrate) 0.

PACKAGE LEAFLET: INFORMATION FOR THE USER. ADRENALINE (TARTRATE) STEROP 1 mg/1 ml Solution for injection. Adrenaline (Levorenine, Epinephrine)

PACKAGE LEAFLET: INFORMATION FOR THE USER. ADRENALINE (HCl) STEROP 0,8mg/1ml. Solution for injection. Adrenaline (Levorenine, Epinephrine)

Perfalgan 10 mg/ml, solution for infusion

PACKAGE LEAFLET: INFORMATION FOR THE USER. PARACETAMOL MACOPHARMA 10 mg/ml, solution for infusion. Paracetamol

Naloxone Hydrochloride Injection PRODUCT INFORMATION

Thioctacid 600 T Solution for Injection contains 600 mg alpha-lipoic acid

1. What Xylocaine with adrenaline is and what it is used for

Package leaflet: Information for the patient. Entyvio 300 mg powder for concentrate for solution for infusion vedolizumab

PACKAGE LEAFLET: INFORMATION FOR THE USER. VITAMINE B12 STEROP 1mg/1ml Solution for injection / oral solution. Cyanocobalamin

Version Number: 5. Patient Group Direction originally drawn up by: Reviewed by: Patient Group direction authorised by: Medical Lead

I B2.4. Design of the patient information leaflet for VariQuin

Package leaflet: Information for the patient. Bricanyl Tablets 5 mg terbutaline sulfate

1 What Anapen is and what it is used for?

2 What you need to know before you have Ampiclox

MEDICATION GUIDE. What is Morphine Sulfate Oral Solution?

Epipen Junior 150 micrograms solution for injection in pre-filled pen

MEDICATION GUIDE mitoxantrone (mito-xan-trone) for injection concentrate

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. [new-ka la]

There is a risk of renal impairment in dehydrated children and adolescents.

1 What Zofran Solution for Injection or Infusion is and what it is used

Always take this medicine exactly as described in this leaflet or as your doctor, pharmacist or nurse have told you.

If you forget to use Catacrom Eye Drops If you forget to use this medicine, use it as soon as you remember.

Summary of the risk management plan (RMP) for Ionsys (fentanyl)

Package leaflet: Information for the patient. Laxido Orange, powder for oral solution

PATIENT MEDICATION INFORMATION

Early Access to Medicines Scheme Treatment protocol Information for patients

Package leaflet: Information for the user. Ondemet 4mg and 8mg Tablets (Ondansetron)

MEDICATION GUIDE ACTOPLUS MET (ak-tō-plus-met) (pioglitazone hydrochloride and metformin hydrochloride) tablets

MEDICATION GUIDE. PROCRIT (PRO KRIT) (epoetin alfa)

Prochlorperazine 3 mg Buccal Tablets (PROCHLORPERAZINE MALEATE)

Package leaflet: Information for the user Naltrexone Hydrochloride 50 mg film-coated tablets Naltrexone Hydrochloride

Share the important information in this Medication Guide with members of your household.

Tradol SR 100mg Prolonged Release Tablets Tramadol hydrochloride

IMPORTANT: PLEASE READ

MEDICATION GUIDE SYLATRON (SY-LA-TRON) (Peginterferon alfa-2b)

Paracetamol apollo Paracetamol apollo Paracetamol

(NON-PRESCRIPTION) LEAFLET: USER INFORMATION. CALTRATE VITAMIN D3 600mg/400 IU, film-coated tablet Calcium and Cholecalciferol

PACKAGE LEAFLET: INFORMATION FOR THE USER. Dalacin C 150 mg Capsules. clindamycin hydrochloride. Dalacin C 150mg Capsules clindamycin hydrochloride

PATIENT INFORMATION LEAFLET. Calcium Sandoz Syrup calcium glubionate and calcium lactobionate

MEDICATION GUIDE SUBOXONE (Sub-OX-own) (buprenorphine and naloxone) Sublingual Film for sublingual or buccal administration (CIII)

SODIUM CHLORIDE 0.9% W/V SOLUTION FOR INJECTION PL 01502/0068 UKPAR TABLE OF CONTENTS

It is important that you tell your family and the people closest to you of this increased sensitivity to opioids and the risk of overdose.

IMIGRAN injection is also used for treatment of cluster headache. Before you use your IMIGRAN injection. When you must not use it

Restandol Testocaps, 40mg CAPSULES, SOFT Testosterone undecanoate

UBISTESIN 1:200,000 and UBISTESIN FORTE 1:100,000

Package Leaflet: Information for the user

Liver Disease & Hepatitis Program Providers: Brian McMahon, MD, Steve Livingston, MD, Lisa Townshend, ANP. Primary Care Provider:

SYNACTHEN i.m./i.v. tetracosactide hexaacetate

!!! BOLUS DOSE IV. Use 5-10 mcg IV boluses STD ADRENALINE INFUSION. Use IM adrenaline in advance of IV dosing!

Package Leaflet: Information for the user Propecia 1 mg film-coated Tablets Finasteride

Package leaflet: Information for the patient

Package leaflet: Information for the user

Package leaflet: Information for the user Humalog 200 units/ml, solution for injection in pre-filled pen insulin lispro

Clinical Performance Director of Nursing Allison Bussey

PATIENT INFORMATION LEAFLET. CEFALEXIN 250 mg AND 500 mg CAPSULES CEFALEXIN

PACKAGE LEAFLET

SYNACTHEN DEPOT i.m. (tetracosactide hexaacetate) 1 mg/ml Suspension for injection

Humulin (HU-mu-lin) R

New Zealand Consumer Medicine Information

MEDICATION GUIDE KOMBIGLYZE XR (kom-be-glyze X-R) (saxagliptin and metformin HCl extended-release) tablets

TdaP-Booster (tee-dee-ay-pee boo-ster)

What you need for Your to know Safety about longterm. opioid pain care. What you need to know about long-term opioid

Read all of this leaflet carefully before you start taking this medicine

Human Normal Immunoglobulin Solution for Intravenous Infusion.

SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT 2 QUALITATIVE AND QUANTITATIVE COMPOSITION

MEDICATION GUIDE. These serious side effects are described below:

Medication Guide KLONOPIN (KLON-oh-pin) (clonazepam) Tablets

Summary of the risk management plan (RMP) for Xultophy (insulin degludec / liraglutide)

Dalacin C 150 mg Hard Capsules Clindamycin (as clindamycin hydrochloride)

PRODUCT MONOGRAPH. Pr PROLOPA. levodopa and benserazide combination. Capsules , , Pharmaceutical standard: professed

Guidelines for the Use of Naloxone in Palliative Care in Adult Patients

MEDICATION GUIDE STELARA

Suspected pulmonary embolism (PE) in pregnant women

PACKAGE LEAFLET: INFORMATION FOR THE USER. /.../ 2.5 mg orodispersible tablets. Desloratadine

NovoRapid is a modern insulin (insulin analogue) with a rapid acting effect. Modern insulin products are improved versions of human insulin.

methadonefact.qxd 8/11/01 2:05 PM Page 1 INFORMATION Advantages of methadone treatment DEPRESSANT Methadone maintenance Pregnancy METHADONE

PATIENT INFORMATION SHEET KEY FACTS

Motilium 1mg/ml Oral Suspension Domperidone

PATIENT INFORMATION LEAFLET

MEDICATION GUIDE POMALYST (POM-uh-list) (pomalidomide) capsules. What is the most important information I should know about POMALYST?

Yes This controlled document shall not be copied in part or whole without the express permission of the author or the author s representative.

TC: Docetaxel and Cyclophosphamide

Package leaflet: Information for the patient. Desloratadine Actavis 5 mg orodispersible tablets desloratadine

N HUMAN Novo Nordisk Patient Information for Novolin N

DRUG INTERACTIONS: WHAT YOU SHOULD KNOW. Council on Family Health

Epinephrine Administration Training for Unlicensed School Personnel

PHENYLEPHRINE HYDROCHLORIDE INJECTION USP


AC: Doxorubicin and Cyclophosphamide

PACKAGE LEAFLET: INFORMATION FOR THE USER. Alvesco 40, 80 and 160 mcg Inhaler Ciclesonide

What Codeine Phosphate Tablets are used for

Medication Guide. SYMLIN (SĬM-lĭn) (pramlintide acetate) injection

Oritavancinn. tissues.

Ask your healthcare provider about LONG-ACTING AVEED (testosterone undecanoate) AVEED TESTOSTERONE INJECTION 5 SHOTS A YEAR. Not an actual patient.

Opioid Agreement for Center for Pain Management S.C.

PACKAGE LEAFLET: INFORMATION FOR THE USER. Synarel 200 micrograms / dose Nasal Spray Solution nafarelin (as acetate)

Testosterone propionate, phenylpropionate, isocaproate and decanoate. Please read this leaflet carefully before you start using SUSTANON 250.

1. What Malarone is and what it is used for

2 What you need to know before you use Imigran nasal spray

Transcription:

A leaflet will be included in each pack. The leaflet will consist of a Technical Information Leaflet and a Patient Information Leaflet. The two leaflets will be easily separatable. The text of the Technical Information Leaflet will be consistent with the approved SmPC. The text of the Patient Information Leaflet will be as follows: Package leaflet: Information for the patient Naloxone Hydrochloride 20 micrograms / ml Solution for Injection Naloxone hydrochloride Read all of this leaflet carefully before your medicine is administered because it contains important information for you. Keep this leaflet. You may want to read it again. If you have any questions, ask your doctor, pharmacist or nurse. If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. What is in this leaflet 1. What Naloxone Hydrochloride is and what it is used for 2. What you need to know before you are given Naloxone Hydrochloride 3. How Naloxone Hydrochloride is given to you 4. Possible side effects 5. How to store Naloxone Hydrochloride 6. Contents of the pack and other information 1. What Naloxone Hydrochloride is and what it is used for Naloxone hydrochloride is a narcotic antidote that can be used to reverse the effects of an overdose. This can be useful in diagnosis of a suspected overdose. Narcotic (or opiate) drugs, in overdose, cause breathing difficulties. Naloxone hydrochloride is used to reverse this effect. This particular dose of Naloxone hydrochloride can help treat asphyxia (an inability to breathe) after someone has received a narcotic drug during labour. It can be used to reverse the depressant effects on breathing in newborn infants (resulting from the use of opioid painkillers in the mother during childbirth). 2. What you need to know before you are given Naloxone Hydrochloride Do not use Naloxone Hydrochloride if: You are allergic to naloxone hydrochloride or any of the other ingredients of this medicine (listed in section 6). Warnings and precautions If you are given naloxone hydrochloride for treatment of acute opiate overdose, you may need to be given other drugs, or a tube placed in your throat, to help you breathe and ensure that your blood circulation continues.

If you have heart disease or are taking drugs known to be harmful to the heart, naloxone may cause further heart problems. Your doctor, and other medical staff looking after you, will know about this and try to keep this under control. Speak to your doctor if this applies to you before you are given this medicine. The effects of some opiates last longer than the effects of naloxone hydrochloride. You may need to be given further doses. If you are addicted to opiates you may experience withdrawal symptoms when you are given naloxone hydrochloride. Speak to your doctor if this applies to you before you are given this medicine. Naloxone is not effective for breathing difficulties not due to opioid drugs. Children Withdrawal symptoms may occur in the newborn children of addicted mothers. Other medicines and Naloxone Hydrochloride No drugs should be added to solutions containing naloxone unless compatibility is known. Naloxone should not be mixed with preparations containing bisulphate, metabisulphate, long chain or high molecular weight anions or those with an alkaline ph. Pregnancy and breast-feeding If you are pregnant: It is not known if Naloxone Hydrochloride is harmful to the unborn child. Naloxone Hydrochloride will only be given to you if it is absolutely essential. Ask your doctor or nurse for advice before you are given this medicine. If you are breast feeding: It is not known if naloxone hydrochloride appears in breast milk. Ask your doctor or nurse for advice before you are given this medicine. Naloxone Hydrochloride contains sodium This medicine contains 9 mg/ml of sodium. Please speak to your doctor if you are on a strict sodium-controlled diet. 3. How Naloxone Hydrochloride is given to you It is usually given by injection into a vein (intravenous or IV). If this is not possible it may be injected into a muscle (intramuscular injection or IM) or just beneath the skin (subcutaneous injection or SC). Sometimes naloxone may be diluted and given as an infusion (drip). The following is listed as a guide. Your doctor may decide that you need more or less than the dose of naloxone hydrochloride indicated here.

Use in Children Opioid overdose - known or suspected: The usual initial dose in children is 10 micrograms/kg body weight given intravenously. If this does not have the desired effect a further dose of 100 mcg/kg body weight may be given. Postoperative opioid respiratory depression: In children the initial dose of naloxone for reversal of respiratory depression should be in increments of 5-10 micrograms (0.25-0.5 ml of 20 microgram/ml strength) intravenously at 2 to 3 minute intervals. The time interval and dose will depend on response to the injection. Use in the Newborn Narcotic induced depression: The usual initial dose is 10 micrograms/kg body weight administered intravenously or alternatively, by intramuscular or subcutaneous injection. This dose may be repeated and will depend on response to the injection. How long you will be given Naloxone Hydrochloride for? You will only be given naloxone until your breathing improves. If you receive more Naloxone Hydrochloride than you should The effects of naloxone, on its own, in overdose are not known. You will be given naloxone by a doctor or paramedic and it is unlikely that you will be given an overdose. If naloxone hydrochloride is given too quickly, or in too high a dose, to patients who have been given or have taken opiate drugs the following effects may occur:- excitement pain killing effect of opiate drugs is lost nausea vomiting sweating palpitations If a dose of Naloxone Hydrochloride is missed Again this is unlikely as you will be given naloxone hydrochloride injection by a doctor or paramedic. Your doctor may decide to miss, delay or reduce a dose, depending on your response to the treatment. If you stop using Naloxone Hydrochloride The effects of naloxone hydrochloride are shorter than the effects of some of the opiate drugs. The effects of the opiate drug may reappear, and you may need to be given further doses of naloxone hydrochloride. If you are addicted to opiate drugs naloxone hydrochloride may cause symptoms of opiate drug withdrawal.

4. Possible side effects Like all medicines, this medicine can cause side effects, although not everybody gets them. In patients with heart disease the following may occur:- fluid on the lungs irregular heart beat heart attack If you notice any difficulty in breathing, palpitations or pains in your chest tell your doctor or nurse. As indicated above, if too much naloxone is given, or if it is given too quickly the following symptoms may occur: excitement pain killing effect of opiate drugs is lost nausea vomiting sweating palpitations tremor over breathing (hyperventilation) Other side effects may include: Very common: (may affect more than 1 in 10 people) Feeling sick Common: (may affect up to 1 in 10 people) Fast heart beat Increased blood pressure Vomiting Uncommon: (may affect up to 1 in 100 people) Tremors Sweating Changes in the way your heart beats Over breathing (hyperventilation) Rare: (may affect up to 1 in 1000 people) Fits (seizures) Seizures have occurred after naloxone hydrochloride, but it is not known if these were caused by the drug. Very Rare: (may affect up to 1 in 10000 people)

Heart attack (cardiac arrest) Fluid in the lungs Reporting of side effects If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via IMB Pharmacovigilance, Earlsfort Terrace, IRL - Dublin 2; Tel: +353 1 6764971; Fax: +353 1 6762517. Website: www.imb.ie; e-mail: imbpharmacovigilance@imb.ie. By reporting side effects you can help provide more information on the safety of this medicine. 5. How to store Naloxone Hydrochloride Keep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the carton, ampoule or blister pack label. Do not store above 25 o C. Keep the ampoule or blister pack in the outer carton in order to protect from light. 6. Contents of the pack and other information What Naloxone Hydrochloride contains The active substance is naloxone hydrochloride. Each 2ml ampoule contains 40 micrograms of naloxone hydrochloride, present as naloxone hydrochloride dihydrate. The other ingredients are water and sodium chloride. What Naloxone Hydrochloride looks like and contents of the pack Naloxone Hydrochloride is a clear, colourless solution, packaged in clear Type I glass ampoules (small bottles) containing 2 ml of solution. These are packaged in cartons containing 5 ampoules, blister packed in perforated strips. Marketing Authorisation Holder & Manufacturer: Hospira UK Limited Queensway Royal Leamington Spa Warwickshire CV31 3RW United Kingdom This leaflet was last revised in March 2014